A seguir

Reprodução automática

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 Visualizações • 07/14/23
Compartilhar
Embutir
administrator
administrator
Assinantes
0

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Mostre mais
0 Comentários sort Ordenar por
Comentários do Facebook

A seguir

Reprodução automática